Profil
Carol Waldo worked as the Vice President of Regulatory Affairs at Cubist Pharmaceuticals LLC.
She then served as the Head of Regulatory Affairs at Spero Therapeutics, Inc. from 2016 to 2019.
Ms. Waldo's most recent position was as the Senior VP of Regulatory Affairs & Quality Assurance at Cidara Therapeutics, Inc. from 2021 to 2023.
She completed her undergraduate degree at North Central College.
Anciens postes connus de Carol Waldo
| Sociétés | Poste | Fin |
|---|---|---|
| CIDARA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2023 |
| SPERO THERAPEUTICS, INC. | Conseiller Juridique Général | 01/02/2019 |
| CUBIST PHARMACEUTICALS INC | Conseiller Juridique Général | - |
Formation de Carol Waldo
| North Central College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SPERO THERAPEUTICS, INC. | Health Technology |
| CIDARA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
